Notably, COVID‐19 patients with heightened serum IL‐37 concentrations have decreased levels of inflammatory cytokines such as IL‐6 and IL‐8, along with improved clinical outcomes, including a shorter hospitalization duration, faster viral nucleic acid clearance time, and expedited resolution of coughing [23]. The gene discussed is IL37; the disease is COVID-19.